2023 - Research.com Materials Science in South Korea Leader Award
2023 - Research.com Chemistry in South Korea Leader Award
His primary areas of investigation include Nanoparticle, Drug delivery, In vivo, Biophysics and Chitosan. His Nanoparticle research entails a greater understanding of Nanotechnology. His Drug delivery study integrates concerns from other disciplines, such as Particle size, Angiogenesis, Drug and Doxorubicin.
His studies deal with areas such as Cancer research, In vitro, Biochemistry and Photodynamic therapy as well as In vivo. His study in Chitosan is interdisciplinary in nature, drawing from both Pyrene, Nuclear chemistry, Stereochemistry, Dynamic light scattering and Sonication. His Drug carrier study combines topics in areas such as Cancer cell, Ethylene glycol, Amphiphile and Micelle.
His scientific interests lie mostly in Nanoparticle, In vivo, Nanotechnology, Biophysics and Drug delivery. His research integrates issues of Chitosan, Conjugated system, Polymer, Fluorescence and Biomedical engineering in his study of Nanoparticle. His biological study deals with issues like Molecular biology, which deal with fields such as Liposome.
His work in Nanotechnology addresses issues such as Photodynamic therapy, which are connected to fields such as Singlet oxygen and Cancer research. His Drug delivery research integrates issues from Tumor targeting and Doxorubicin. The concepts of his Drug carrier study are interwoven with issues in Amphiphile and Micelle.
His primary areas of study are In vivo, Nanotechnology, Biophysics, Nanoparticle and Cancer research. His In vivo research incorporates elements of In vitro, Drug delivery and Pharmacology. The Nanotechnology study combines topics in areas such as Optical imaging, Cancer therapy, Photodynamic therapy and Cytotoxicity.
His studies in Biophysics integrate themes in fields like Cytoplasm, Biochemistry, Small interfering RNA, Ethylene glycol and Gene silencing. The various areas that Ick Chan Kwon examines in his Nanoparticle study include Chitosan, Targeted drug delivery and Fluorescence. In Cancer research, Ick Chan Kwon works on issues like Pathology, which are connected to Matrix metalloproteinase.
Ick Chan Kwon mainly focuses on In vivo, Nanotechnology, Drug delivery, Cancer research and Nanoparticle. His research in In vivo intersects with topics in Cell, Sonodynamic therapy, Click chemistry, Bioorthogonal chemistry and Azide. His Nanotechnology research incorporates themes from Therapeutic modalities, Personalized medicine, Photodynamic therapy and Drug release.
The Drug delivery study combines topics in areas such as Pharmacology and Doxorubicin. His Cancer research research is multidisciplinary, relying on both Cancer, Systemic administration, Reactive oxygen species, Immunology and Pathology. His Nanoparticle study frequently draws connections between related disciplines such as Biomedical engineering.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Multifunctional nanoparticles for multimodal imaging and theragnosis
Dong Eun Lee;Heebeom Koo;In Cheol Sun;Ju Hee Ryu.
Chemical Society Reviews (2012)
Targeted delivery of low molecular drugs using chitosan and its derivatives.
Jae Hyung Park;Gurusamy Saravanakumar;Kwang Meyung Kim;Ick Chan Kwon.
Advanced Drug Delivery Reviews (2010)
Electrically erodible polymer gel for controlled release of drugs.
Ick Chan Kwon;You Han Bae;Sung Wan Kim.
Nature (1991)
Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles
Hae Yun Nam;Seok Min Kwon;Seok Min Kwon;Hyunjin Chung;Hyunjin Chung;Seung Young Lee.
Journal of Controlled Release (2009)
Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
Ki Young Choi;Hyunjin Chung;Hyunjin Chung;Kyung Hyun Min;Kyung Hyun Min;Hong Yeol Yoon.
Biomaterials (2010)
Polymeric nanomedicine for cancer therapy
Jae Hyung Park;Seulki Lee;Jong Ho Kim;Kyeongsoon Park.
Progress in Polymer Science (2008)
Preparation of chitosan self-aggregates as a gene delivery system.
K.Y Lee;I.C Kwon;Y.-H Kim;W.H Jo.
Journal of Controlled Release (1998)
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Kyung Hyun Min;Kyeongsoon Park;Yoo Shin Kim;Sang Mun Bae.
Journal of Controlled Release (2008)
New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy
Kyeongsoon Park;Seulki Lee;Eunah Kang;Kwangmeyung Kim.
Advanced Functional Materials (2009)
Super pH-sensitive multifunctional polymeric micelle for tumor pHe specific TAT exposure and multidrug resistance
Eun Seong Lee;Zhonggao Gao;Dongin Kim;Kyeongsoon Park.
Journal of Controlled Release (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Korea Institute of Science and Technology
Kyung Hee University
Korea Institute of Science and Technology
Korea Institute of Science and Technology
Sungkyunkwan University
Purdue University West Lafayette
Hanyang University
University of Utah
Sungkyunkwan University
Seoul National University
Stanford University
McGill University
Indian Institute of Technology Madras
Embrapa Instrumentation
National University of Singapore
A*STAR - Agency for Science, Technology and Research
CEA LETI
University of Brescia
University of Bergen
South China Normal University
Mayo Clinic
National Institute of Allergy and Infectious Diseases
Reithera
Fred Hutchinson Cancer Research Center
University of Eastern Finland
Los Alamos National Laboratory